App with rewards boosts cancer screening decisions in pilot trial
NCT ID NCT07269028
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a smartphone app that uses quizzes and rewards to help people make informed choices about colorectal cancer screening. 248 adults in Italy were randomly assigned to use either the gamified app or a basic information app. The researchers measured whether participants made an informed decision and actually completed screening. The goal is to see if a fun, personalized app can overcome barriers to screening participation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gamified mobile app with personalized questionnaires and rewards
- What this could lead to
- If successful, this approach could increase informed participation in colorectal cancer screening programs.
- What could go wrong
- This is a small pilot study (248 participants) in one region of Italy, so results may not apply broadly. The app's impact on actual screening behavior is still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Agenzia per la Tutela della Salute (ATS) di Brescia
Brescia, Brescia, 25123, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a registry make endoscopic procedures safer and more effective?
- A new clue in the fight against colorectal cancer recurrence?
- One simple score to rate colorectal cancer surgery quality?
- Engineered virus joins forces with immunotherapy to fight resistant cancers
- Massive 30-Year Women's health study reveals hidden disease links